All lobbying filings
THE MCMANUS GROUP
Lobbying for EMD SERONO, INC. · Client is a biopharmaceutical company.
Filing
1st Quarter - Report
Lobbying activity
2
General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products. Issues related to reforming and increasing transparency within the 340B Drug Pricing Program. Issues related to IVF treatments.
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.